US Patent Issued to Amgen, Amgen Research (Munich), Immatics Biotechnologies on May 27 for "MAGEB2 binding constructs" (German, Canadian, American Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,412, issued on May 27, was assigned to Amgen Inc. (Thousand Oaks, Calif.), Amgen Research (Munich) GmbH (Munich) and Immatics Biotechnologies GmbH (Tubingen, Germany).

"MAGEB2 binding constructs" was invented by Ian Nevin Foltz (Burnaby, Canada), Weihsu Claire Chen (Vancouver, Canada), Lars Gaedtke (Munich), Susmith Mukund (Foster City, Calif.), Tobias Raum (Eurasburg, Germany), Heiko Schuster (Tubingen, Germany), Kristin Tarbell (Millbrae, Calif.), Derek E. Piper (Santa Clara, Calif.), Johannes Brozy (Munich), Markus Muenz (Lenggries, Germany), Igor D'Angelo (Carlsbad, Calif.) and Alexander Sternjak (Munich).

According to the abstract* released by the U.S. Patent & Trademark Off...